• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer.联合外泌体RNA和循环肿瘤DNA用于非小细胞肺癌表皮生长因子突变检测
J Thorac Dis. 2018 Nov;10(Suppl 33):S4023-S4027. doi: 10.21037/jtd.2018.10.17.
2
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma.在非小细胞肺癌患者血浆中使用外泌体RNA和循环肿瘤DNA联合检测改善表皮生长因子受体（EGFR）突变检测
Ann Oncol. 2018 Oct 1;29(10):2143. doi: 10.1093/annonc/mdy261.
3
Exosome-Based Detection of T790M in Plasma from Non-Small Cell Lung Cancer Patients.基于外泌体的非小细胞肺癌患者血浆 T790M 检测。
Clin Cancer Res. 2018 Jun 15;24(12):2944-2950. doi: 10.1158/1078-0432.CCR-17-3369. Epub 2018 Mar 13.
4
Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer.循环血浆微小RNA作为鉴定晚期非小细胞肺癌患者表皮生长因子受体（EGFR）突变状态及监测表皮生长因子受体-酪氨酸激酶抑制剂治疗的潜在标志物。
Oncotarget. 2017 Jul 11;8(28):45807-45824. doi: 10.18632/oncotarget.17416.
5
Rapid detection of epidermal growth factor receptor mutations in non-small cell lung cancer using real-time polymerase chain reaction with TaqMan-MGB probes.使用TaqMan-MGB探针的实时聚合酶链反应快速检测非小细胞肺癌中的表皮生长因子受体突变
Cancer J. 2006 Jan-Feb;12(1):33-9. doi: 10.1097/00130404-200601000-00007.
6
Detection of EGFR Mutations in Circulating Tumor DNA (ctDNA) Retrieved from Plasma - Interlaboratory Quality Assessment in the Czech Republic.从血浆中提取的循环肿瘤DNA（ctDNA）中EGFR突变的检测——捷克共和国的实验室间质量评估
Klin Onkol. 2018 Fall;31(5):353-360. doi: 10.14735/amko2018353.
7
Clinical Features of Patients with an Epidermal Growth Factor Receptor T790M Mutation Detected in Circulating Tumor DNA.循环肿瘤 DNA 中检测到表皮生长因子受体 T790M 突变的患者的临床特征。
Oncology. 2020;98(1):23-28. doi: 10.1159/000502528. Epub 2019 Sep 6.
8
Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer.采用基于芯片的数字PCR系统对晚期非小细胞肺癌患者进行血浆表皮生长因子受体突变检测。
Lung Cancer. 2017 Apr;106:138-144. doi: 10.1016/j.lungcan.2017.02.001. Epub 2017 Feb 4.
9
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.评估非小细胞肺癌中的循环肿瘤细胞和循环肿瘤 DNA：在曲妥珠单抗和厄洛替尼的 II 期临床试验中与临床终点的关联。
Clin Cancer Res. 2012 Apr 15;18(8):2391-401. doi: 10.1158/1078-0432.CCR-11-3148. Epub 2012 Apr 5.
10
The close correlation between 8-hydroxy-2'-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer.8- 羟基 -2'- 脱氧鸟苷与非小细胞肺癌表皮生长因子受体激活突变之间的密切相关性。
Hum Pathol. 2010 Jul;41(7):951-9. doi: 10.1016/j.humpath.2009.12.007. Epub 2010 Mar 17.

引用本文的文献

1
Relationship between exosomes and cancer: formation, diagnosis, and treatment.外泌体与癌症的关系：形成、诊断及治疗
Int J Biol Sci. 2025 Jan 1;21(1):40-62. doi: 10.7150/ijbs.95763. eCollection 2025.
2
The Role of Cell-Free DNA in Cancer Treatment Decision Making.游离DNA在癌症治疗决策中的作用。
Cancers (Basel). 2022 Dec 12;14(24):6115. doi: 10.3390/cancers14246115.
3
Case report: gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib.病例报告：一名转移性肺腺癌患者的基因融合通过恩曲替尼成功治疗。
Front Oncol. 2022 Nov 7;12:1038774. doi: 10.3389/fonc.2022.1038774. eCollection 2022.
4
New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies.外泌体介导的肿瘤免疫逃逸的新见解：临床观点和治疗策略。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188624. doi: 10.1016/j.bbcan.2021.188624. Epub 2021 Sep 3.

本文引用的文献

1
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma.在非小细胞肺癌患者血浆中使用外泌体RNA和循环肿瘤DNA联合检测改善表皮生长因子受体（EGFR）突变检测
Ann Oncol. 2018 Oct 1;29(10):2143. doi: 10.1093/annonc/mdy261.
2
Monitoring -T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.监测血清/血浆中的T790M突变以预测肺癌患者对第三代EGFR抑制剂的反应。
Oncotarget. 2018 Jun 5;9(43):27074-27086. doi: 10.18632/oncotarget.25478.
3
Extracellular vesicles in cancer - implications for future improvements in cancer care.癌症中的细胞外囊泡 - 对未来改善癌症治疗的影响。
Nat Rev Clin Oncol. 2018 Oct;15(10):617-638. doi: 10.1038/s41571-018-0036-9.
4
Liquid biopsy for lung cancer early detection.用于肺癌早期检测的液体活检
J Thorac Dis. 2018 Apr;10(Suppl 7):S882-S897. doi: 10.21037/jtd.2018.03.81.
5
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy.奥希替尼治疗非小细胞肺癌：设计、研发及在治疗中的地位
Lung Cancer (Auckl). 2017 Aug 18;8:109-125. doi: 10.2147/LCTT.S119644. eCollection 2017.
6
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.基于肿瘤驯化血小板的群体智能增强型非小细胞肺癌检测
Cancer Cell. 2017 Aug 14;32(2):238-252.e9. doi: 10.1016/j.ccell.2017.07.004.
7
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.奥希替尼或铂类培美曲塞用于治疗表皮生长因子受体T790M阳性肺癌
N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6.
8
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer.晚期非小细胞肺癌患者血浆基因分型与奥希替尼（AZD9291）治疗结果的相关性
J Clin Oncol. 2016 Oct 1;34(28):3375-82. doi: 10.1200/JCO.2016.66.7162. Epub 2016 Jun 27.
9
Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.血浆表皮生长因子受体（EGFR）T790M循环肿瘤DNA（ctDNA）状态与获得性EGFR酪氨酸激酶抑制剂（TKI）耐药的晚期非小细胞肺癌（NSCLC）患者的临床结局相关。
Sci Rep. 2016 Feb 12;6:20913. doi: 10.1038/srep20913.
10
Large-scale screening for somatic mutations in lung cancer.肺癌体细胞突变的大规模筛查。
Lancet. 2016 Apr 2;387(10026):1354-1356. doi: 10.1016/S0140-6736(15)01125-3. Epub 2016 Jan 15.

Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer.

作者信息

Lazzari Chiara, Gregorc Vanesa, Cangi Maria Giulia, Giovannetti Elisa, Bulotta Alessandra, Santarpia Mariacarmela

机构信息

Department of Oncology, Division of Experimental Medicine, IRCCS San Raffaele, Milan, Italy.

Unit of Pathology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

J Thorac Dis. 2018 Nov;10(Suppl 33):S4023-S4027. doi: 10.21037/jtd.2018.10.17.

DOI:10.21037/jtd.2018.10.17
PMID:30631545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6297534/
Abstract
摘要